Skip NavigationSkip to Content

An in vitro and computational validation of a novel loss-of-functional mutation in PAX9 associated with non-syndromic tooth agenesis

  1. Author:
    Sarkar,Tanmoy [ORCID]
    Ranjan, Prashant [ORCID]
    Kanathur, Smitha [ORCID]
    Gupta, Ankush [ORCID]
    Das, Parimal [ORCID]
  2. Author Address

    Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Uttar Pradesh, Varanasi, 221005, India., Mouse Cancer Genetics Program, Center for Cancer Research, NCI-NIH, Fort Detrick, Frederick, MD, USA., Department of Periodontology, Government Dental College and Research Institute, Bangalore, India., Department of Biochemistry, Institute of Science, Banaras Hindu University, Uttar Pradesh, Varanasi, India., Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Uttar Pradesh, Varanasi, 221005, India. parimal@bhu.ac.in.,
    1. Year: 2022
    2. Date: Nov 14
    3. Epub Date: 2022 11 14
  1. Journal: Molecular Genetics and Genomics : MGG
  2. Type of Article: Article
  1. Abstract:

    Congenital tooth agenesis (CTA) is one of the most common craniofacial anomalies. Its frequency varies among different population depending upon the genetic heterogeneity. CTA could be of familial or sporadic and syndromic or non-syndromic. Five major genes are found to be associated with non-syndromic CTA, namely PAX9, MSX1, EDA1, AXIN2, and WNT10A. Very few studies have been carried out so far on CTA on this Indian population making this study unique and important. This study was initiated to identify potential pathogenic variant associated with congenital tooth agenesis in an India family with molar tooth agenesis. CTA was investigated and a novel c.336C?>?G variation was identified in the exon 3 of PAX9, leading to substitution of evolutionary conserved Cys with Trp at 112th amino acid position located at the functionally significant DNA-binding paired domain region. Functional analysis revealed that p.Cys112Trp mutation did not prevent the nuclear localization although mutant protein had higher cytoplasmic retention. EMSA using e5 probe revealed that mutant protein was unable to bind with the paired-domain-binding site. Subsequently, GST pull-down assay revealed lower binding activity of the mutant protein with its known interactor MSX1. These in vitro results were consistent with the computational results. The in vitro and computational observations altogether suggest that c.336C?>?G (p.Cys112Trp) variation leads to loss of function of PAX9 leading to CTA in this family. © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

    See More

External Sources

  1. DOI: 10.1007/s00438-022-01970-7
  2. PMID: 36374296
  3. PII : 10.1007/s00438-022-01970-7

Library Notes

  1. Fiscal Year: FY2022-2023
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel